Submit
logo

Baroda BNP Paribas Health and Wellness Fund Regular Growth

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 09-06-2025
AUM:

₹ 530.21 Cr

Expense Ratio

2.46%

Benchmark

BSE Healthcare TRI

ISIN

INF251K01UY7

Minimum Investment

1000.0

Minimum Topup

1000.0

Minimum SIP Amount

500

Fund Manager

Mr. Sanjay Chawla, Mr. Rohan Korde

Fund Performance 1Y (%) 3Y (%) 5Y (%)
Baroda BNP Paribas Health and Wellness Fund Regular Growth - - -
Benchmark - - -
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
9.9591
Last change
0.09 (0.8806%)
Fund Size (AUM)
₹ 530.21 Cr
Performance
-0.51% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

Fund Manager
Mr. Sanjay Chawla, Mr. Rohan Korde
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- 9.38
LUPIN LIMITED EQ NEW F.V. RS.2/- 6.09
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- 5.34
ABBOTT INDIA LIMITED EQ 5.28
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- 5.13
LAURUS LABS LIMITED EQ NEW FV RS. 2/- 4.78
FORTIS HEALTHCARE LIMITED. EQ 4.35
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- 4.32
JB Chemicals & Pharmaceuticals Limited 4.24
ASTRAZENECA PHARMA INDIA LIMITED EQ NEW FV RS.2/- 4.03

Sector Allocation

Sector Holdings (%)
Healthcare 86.77
Financial Services 7.29
Consumer Services 1.64
Information Technology 1.56

Peer Comparison

Scheme Name 5Y (%)
Baroda BNP Paribas Health and Wellness Fund Reg Gr 0.0